Product Search

STAFEN Cap.

Product Infomation
Category	Cardiovascular Related Agents
Composition	Each capsule contains Pitavastatin calcium 2mg, Fenofibrate 160mg
Indications	Treatment for complex-dyslipidemeia (or combined hyperlipidemia) patients with high risk for Coronary Heart Disease (CHD) whose LDL-Cholesterol level is adequately controlled by pitavastatin 2mg monotherapy, wihle their triglyceride level remains high and HDL-Cholesterol level remains low.
Packing	30Caps/PTP
Shelf life	3 years